ZBH
ZBH
US98956P1021
Zimmer Biomet Holdings, Inc.
Loading chart...

Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Latest News

Related stocks

PEN
PEN • United States
Penumbra, Inc.
319.4 USD
12.58B USD 1Y +22.6%
STE
STE • United States
STERIS plc (Ireland)
214.4 USD
20.9B USD 1Y -13%
GKOS
GKOS • United States
Glaukos Corporation
165.69 USD
9.77B USD 1Y +84.1%
GEHC
GEHC • United States
GE HealthCare Technologies Inc.
65.74 USD
29.9B USD 1Y -14.5%
GMED
GMED • United States
Globus Medical, Inc.
74.65 USD
10.02B USD 1Y +21.4%
HAE
HAE • United States
Haemonetics Corporation
118.69 USD
5.4B USD 1Y +134.3%
BSX
BSX • United States
Boston Scientific Corporation
42.73 USD
61.93B USD 1Y -56.6%
BIO
BIO • United States
Bio-Rad Laboratories, Inc.
366.16 USD
9.8B USD 1Y +19%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
27.1% p.a.
Max Drawdown (5Y)
-45.7%
Sharpe Ratio (5Y)
-0.42
Beta Factor
0.48
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -54.1% in the extended horizon.
ende